Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
When would you offer definitive or adjuvant RT for solitary fibrous tumor or hemangiopericytoma in the head and neck?
Answer from: Radiation Oncologist at Academic Institution
Incompletely resectable or close or positive margins
Sign in or Register to read more
20141
Related Questions
What is your radiation dose/volume for adjuvant treatment of a clear cell odontogenic carcinoma of the mandible after segmental resection?
In oral cavity cancers, how does WPOI (worse pattern of invasion) influence your decision to offer adjuvant therapy?
Is there a role for reirradiation for SCC oral tongue with high-risk features (i.e., PNI, close margins) following surgery?
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
What dose are you routinely using for adjuvant RT for intermediate risk p16+ SCC of the OPX s/p TORS?
How would you approach an early stage p16+ SCC of the tonsil s/p TORS and neck dissection with initial positive margins but then negative on re-resection?
What is your approach to reporting mandible dose received to the dentist/oral surgeon?
How should you approach treating curable laryngeal cancer with chemo-RT in a patient who had a myocardial infarction during treatment and requires CABG, given the cardiotoxicity of cisplatin and 5FU/carboplatin?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
Is there a role for bromhexine for thick secretions during/after head and neck RT?